MicroRNA-125a-5p Is a Downstream Effector of Sorafenib in Its Antiproliferative Activity Toward Human Hepatocellular Carcinoma Cells-Reference-Cited by-同舟云学术

MicroRNA-125a-5p Is a Downstream Effector of Sorafenib in Its Antiproliferative Activity Toward Human Hepatocellular Carcinoma Cells

Published:2017-02-16 Issue:7 Volume:232 Page:1907-1913
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J. Cell. Physiol.

Author:

Potenza Nicoletta¹,Mosca Nicola¹,Zappavigna Silvia²,Castiello Filomena¹,Panella Marta¹,Ferri Carmela²,Vanacore Daniela²,Giordano Antonio³,Stiuso Paola²,Caraglia Michele²,Russo Aniello¹

Affiliation:

1. Department of Environmental, Biological and Pharmaceutical Sciences and Technologies; University of Campania “L. Vanvitelli”; Caserta Italy

2. Department of Biochemistry, Biophysics and General Pathology; University of Campania “L. Vanvitelli”; Naples Italy

3. Sbarro Institute for Cancer Research and Molecular Medicine & Center for Biotechnology; Temple University; Philadelphia Pennsylvania

Funder

Regione Campania

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Reference54 articles.

1. The functions of animal microRNAs;Ambros;Nature,2004

2. Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells;Ambrosini;Mol Cancer Ther,2008

3. New therapies for hepatocellular carcinoma;Avila;Oncogene,2006

4. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib;Bai;J Biol Chem,2009

5. MicroRNAs: Genomics, biogenesis, mechanism, and function;Bartel;Cell,2004

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osteosarcoma in a ceRNET perspective;Journal of Biomedical Science;2024-06-05

2. A Novel ceRNET Relying on the lncRNA JPX, miR-378a-3p, and Its mRNA Targets in Lung Cancer;Cancers;2024-04-17

3. Low expression of miR125a-5p predicts sensitivity to sorafenib by upregulating STAT3 and HTATIP2 in hepatocellular carcinoma;2023-12-19

4. Role of sirtuins in hepatocellular carcinoma progression and multidrug resistance: Mechanistical and pharmacological perspectives;Biochemical Pharmacology;2023-06

5. Making Sense of Antisense lncRNAs in Hepatocellular Carcinoma;International Journal of Molecular Sciences;2023-05-17